The development of laser technology over the last few years has improved vision for many people. At the Ophthalmos Research & Educational Institute we are using the latest laser technology with the aim of dramatically reducing Intraocular pressure. This method in medical terms is called S.L.T., the Selective Laser Trabeculoplasty. For some patients this treatment comes as a welcome solution to their problem, when the use of anti-glaucoma drops are ineffective, causing poor quality of vision.
Glaucoma is a term used to describe a group of diseases characterised by optic nerve fibre damage. The optic nerve is made up of nerve fibres which transport the picture we see to the brain. It is easier to imagine this by likening the optic nerve to a “wire” which transports information. When a person suffers from this condition the “wire” transports less and less information, due to the deterioration of the optic nerve, resulting in the limitation of the visual field. In cases where medical advice is not sought from a specialist ophthalmic surgeon, it is likely that the person may have total loss of sight.
Glaucoma by rule is an asymptomatic disease. Unfortunately when the first symptoms appear the damage is severe and irreversible. Patients with glaucoma do not realise the presence of the disease as they have no symptoms, with the exception of acute glaucoma. Prevention is of upmost importance as late diagnosis and treatment leads to blindness.